Buy & Sell Sunrun Inc (RUN) – Sunrun Inc Price Today
Aura AI Summary
Key Stats
- $3.27BMarket Cap
- TechnologySector
- -44.52%3M Drawdown
- $17.46BEnterprise Value
- -Dividend Yield
- 69% Buy | 31% SellTrading Activity
- 15 daysTypical Hold Time
Sunrun Inc (RUN) is currently valued at a market capitalization of $3.27B, with an enterprise value of $17.46B. Over the past 52 weeks, Sunrun Inc has traded between a low of $5.78 and a high of $21.41, highlighting its annual price range. Over the past three months, Sunrun Inc has recorded a drawdown of -44.52%, reflecting recent price volatility. On average, investors hold Sunrun Inc for approximately 15 days, indicating typical investor behavior on the platform.
About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Most Recent News
BlackSky to present at three key investor conferences in May and June 2026
BlackSky Technology Inc. announced its participation in three upcoming investor conferences: the Jefferies Virtual Space Summit on May 26, the 23rd Annual Craig-Hallum Institutional Investor Conference on May 28, and the Morgan Stanley National Secur...

LiquidStack launches GigaModular™ liquid cooling platform with 14 MW capacity for AI data centers
LiquidStack, a Trane Technologies company, has commercially launched its GigaModular™ CDU platform designed for high-density AI data centers. The platform offers flexible, scalable liquid cooling capacity up to 14 MW, enabling operators to expand coo...

Inventiva to present at 2026 Jefferies Global Healthcare Conference in June
Inventiva, a biopharmaceutical company developing oral therapy for metabolic dysfunction-associated steatohepatitis (MASH), announced its CEO Andrew Obenshain will present at the 2026 Jefferies Global Healthcare Conference in New York on June 3. The ...
